申请人:——
公开号:US20020151561A1
公开(公告)日:2002-10-17
The present invention provides novel thienopyridines, novel compositions, methods of their use, and methods of their manufacture, where such compounds of Formula 1 are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) including PTP1B, T cell PTP,
1
wherein X, R
1
, R
2
, R
3
, and R
4
are defined more fully in the description. The compounds are useful in the treatment of type 1 diabetes, type 2 diabetes, impaired glucose tolerance, insulin resistance, obesity, and other diseases.
本发明提供了新型噻吩吡啶类化合物,新型组合物,其使用方法以及制备方法,其中Formula 1中的这些化合物在药理学上是蛋白酪氨酸磷酸酶(PTPase's)的有用抑制剂,包括PTP1B、T细胞PTP等,其中X、R1、R2、R3和R4在描述中有更详细的定义。这些化合物在治疗1型糖尿病、2型糖尿病、糖耐量受损、胰岛素抵抗、肥胖和其他疾病方面具有用处。